{
    "clinical_study": {
        "@rank": "40063", 
        "arm_group": [
            {
                "arm_group_label": "Acetazolamide", 
                "arm_group_type": "Active Comparator", 
                "description": "Acetazolamide 1 g in 10 ml saline, i.v. infusion"
            }, 
            {
                "arm_group_label": "Saline", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Saline, 10 ml i.v. infusion"
            }
        ], 
        "brief_summary": {
            "textblock": "In this study the investigators will research the hypothesis that the drug Acetazolamide\n      induce headache and dilation of cerebral arteries and increase the cerebral blood flow in\n      the areas of the brain supplied by these arteries."
        }, 
        "brief_title": "Acetazolamide's Headache Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Headache", 
            "Migraine"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Headache", 
                "Migraine Disorders"
            ]
        }, 
        "detailed_description": {
            "textblock": "To investigate headache score and accompanying symptoms during and after infusion of\n      acetazolamide.\n\n      With magnetic resonance imaging the investigators will investigate changes in regional\n      cerebral blood flow (rCBF) in the area supplied by middle cerebral artery (MCA), diameter of\n      MCA, the Internal carotic artery (ICA), the superficial temporal artery (STA) and the Medial\n      Meningeal artery (MMA)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy volunteers\n\n          -  Aged 18-40\n\n          -  50-100 kg\n\n          -  Fertile women must use safe contraceptives (IUD, oral contraceptives, surgical\n             sterilisation and long lasting gestagen.\n\n        Exclusion Criteria:\n\n          -  Tension type headache more than once/month\n\n          -  Other primary headaches\n\n          -  Daily medication except contraceptives\n\n          -  Drug taken within 4 times the halflife for the specific drug except contraceptives\n\n          -  Pregnant or lactating women\n\n          -  Exposure to radiation within the last year\n\n          -  Headache within the last 24 hours before start of trial\n\n          -  Hypertension\n\n          -  Hypotension\n\n          -  Respiratory or cardiac disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 11, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01750723", 
            "org_study_id": "H-3-2012-137"
        }, 
        "intervention": {
            "arm_group_label": "Acetazolamide", 
            "description": "1 g diluted in 10 ml saline, i.v. bolus injection.", 
            "intervention_name": "Acetazolamide", 
            "intervention_type": "Drug", 
            "other_name": "Diamox"
        }, 
        "intervention_browse": {
            "mesh_term": "Acetazolamide"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Acetazolamide", 
            "Headache", 
            "Migraine"
        ], 
        "lastchanged_date": "July 8, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Copenhagen", 
                        "country": "Denmark", 
                        "state": "Glostrup", 
                        "zip": "2600"
                    }, 
                    "name": "Danish Headache Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Copenhagen", 
                        "country": "Denmark", 
                        "state": "Glostrup", 
                        "zip": "2600"
                    }, 
                    "name": "Department of Neurology"
                }
            }
        ], 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "Basic Research on Acetazolamide\u00b4s Headache Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow in a Humane Experimental Headache Model", 
        "overall_official": {
            "affiliation": "Danish Headache Center", 
            "last_name": "Nanna Arngrim, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Denmark: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Comparison between Acetazolamide and placebo (saline).", 
            "measure": "Headache scores", 
            "safety_issue": "No", 
            "time_frame": "24 h"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01750723"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Danish Headache Center", 
            "investigator_full_name": "Nanna Arngrim", 
            "investigator_title": "MD, medical doctor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Acetazolamide induced changes in intracranial artery circumference before and after infusions.", 
                "measure": "Artery circumference", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 30 min and 60 min"
            }, 
            {
                "description": "Acetazolamide induced changes in cerebral blood flow.", 
                "measure": "Cerebral blood flow", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 30 and 60 min."
            }
        ], 
        "source": "Danish Headache Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Danish Headache Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}